WNT-pathway medulloblastoma: what constitutes low-risk and how low can one go?

Novel biological insights have established that medulloblastoma is a heterogenous disease comprising four broad molecular subgroups - WNT, SHH, Group 3, and Group 4 respectively, resulting in the incorporation of molecular/genetic information in 5th edition of WHO classification and contemporary ris...

Descripción completa

Detalles Bibliográficos
Autores principales: Mani, Shakthivel, Chatterjee, Abhishek, Dasgupta, Archya, Shirsat, Neelam, Epari, Sridhar, Chinnaswamy, Girish, Gupta, Tejpal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2023
Materias:
Research Perspective
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9904321/
https://www.ncbi.nlm.nih.gov/pubmed/36749287
http://dx.doi.org/10.18632/oncotarget.28360

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9904321/
https://www.ncbi.nlm.nih.gov/pubmed/36749287
http://dx.doi.org/10.18632/oncotarget.28360

Ejemplares similares